FAST READ
- India crossed 80 lakh HPV vaccine doses under the national campaign launched in February 2026.
- The programme provides free, voluntary, single-dose HPV vaccination to 14-year-old girls at government health facilities with parental consent.
- Gujarat, Uttar Pradesh, Madhya Pradesh and Mizoram reached 100% of their identified target cohorts; Bihar, Andhra Pradesh and Assam crossed 90%.
WHY IN NEWS
- The milestone makes adolescent vaccination and cervical-cancer prevention a major public-health current-affairs issue.
- The campaign also shows how U-WIN can be used for district-level monitoring, missed-beneficiary identification and programme planning.
TOP DATA & FACTS
- More than 80 lakh HPV vaccine doses had been administered by 11 September 2026.
- The campaign was launched in February 2026.
- The target group is 14-year-old girls.
- Vaccination is free of cost at government health facilities.
- Vaccination is voluntary and requires parental consent.
- The public programme uses a single-dose schedule.
- RGI 2021 estimates place the annual cohort of 14-year-old girls at about 1.2 crore.
- Uttar Pradesh had vaccinated more than 22 lakh adolescent girls.
- Gujarat achieved 100% coverage of its identified target population.
- Uttar Pradesh, Madhya Pradesh and Mizoram also achieved 100% identified-cohort coverage.
- Bihar, Andhra Pradesh and Assam crossed 90% coverage.
- Karnataka crossed 85% coverage.
- More than 800 million HPV vaccine doses have been distributed globally.
- U-WIN supports district-level monitoring of vaccination coverage.
- Government sessions are linked to 24x7 facilities for management of rare AEFI.
PRELIMS
- HPV is a major cause of cervical cancer.
- Vaccination is preventive; it does not replace screening in eligible women.
- The national campaign targets 14-year-old girls.
- U-WIN is a digital vaccination-management platform.
- AEFI means Adverse Event Following Immunization.
- Population-level cancer prevention combines vaccination, screening, diagnosis and treatment.
QUICK REVISION
- 80 lakh+ doses by 11 Sep 2026.
- Target: 14-year-old girls; free, voluntary, single dose.
- Annual cohort: about 1.2 crore girls.